186748-46-9

Usage

Chemical Class

2-(4-bromo-2,6-dimethylphenyl)acetic acid belongs to the class of acetic acid derivatives.

Physical Appearance

It is a white crystalline solid.

Usage

The compound is widely used in organic synthesis and pharmaceutical research.

Pharmacological Properties

It has potential pharmacological properties, particularly in the treatment of pain and inflammation.

Importance in Synthesis

The bromo and methyl groups on the phenyl ring make 2-(4-bromo-2,6-dimethylphenyl)acetic acid a valuable intermediate in the synthesis of various pharmaceuticals and fine chemicals.

Industrial Applications

As a result of its wide range of applications, 2-(4-bromo-2,6-dimethylphenyl)acetic acid is an important compound in the pharmaceutical and chemical industries.

Upstream product

• 17100-59-3 (4-bromo-2,6-dimethylphenyl)methanol 
• 205035-09-2 2-(4-bromo-2,6-dimethylphenyl)acetonitrile 

Downstream Products

• 1615201-93-8 2-(2,6-dimethyl-4-prop-1-ynylphenyl)-3-(methoxycarbonyloxy)-5-(pyridin-2-yl)cyclohex-2-en-1-one 
• 1615201-92-7 2-(2,6-dimethyl-4-prop-1-ynylphenyl)-5-(pyridin-2-yl)cyclohexane-1,3-dione hydrochloride 
• 1615211-94-3 2-(2,6-dimethyl-4-prop-1-ynylphenyl)-3-methoxy-5-(2-pyridyl)cyclohex-2-en-1-one 
• 1615211-93-2 2-(4-bromo-2,6-dimethylphenyl)-3-methoxy-5-(2-pyridyl)cyclohex-2-en-1-one 
• 1615211-92-1 C₁₉H₁₈BrNO₂ 
• 1615211-90-9 1-(4-bromo-2,6-dimethylphenyl)-4-(pyridin-2-yl)but-3-en-2-one 
• 1615211-89-6 1-(4-bromo-2,6-dimethylphenyl)propan 

Relevant academic research and scientific papers

PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS

The present invention relates to phenyl derivatives of formula (I) Formula (I) wherein (R1)n, R3, R4a, R4b, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (III) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.